2. Peptides
  3. Peptide and Derivatives
  4. β-Amyloid and Tau Peptides
  5. Tau Peptides

Tau peptides are peptide fragments derived from the microtubule-associated protein Tau, which is involved in the development of Alzheimer's disease and other neurodegenerative conditions.

Tau Peptides (35):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P1675A
    Acetyl-PHF6 amide TFA 99.75%
    Acetyl-PHF6 amide TFA (AcPHF6 TFA) is a tau derived hexapeptide.
    Acetyl-PHF6 amide TFA
  • HY-P1707A
    Tau protein (592-597), human TFA 2703746-44-3
    Tau protein (592-597), human TFA is a peptide fragment of human Tau protein. The dysfunction of Tau protein is involved in neurodegeneration and dementia.
    Tau protein (592-597), human TFA
  • HY-P4808
    PHF6 329897-62-3 99.17%
    PHF6 (VQIVYK) is a self-assembly sequence capable of initiating the full-length tau protein aggregation and is mapped to the third microtubule-binding repeat region of the tau protein.
    PHF6
  • HY-P2516
    Tau Peptide (275-305) (Repeat 2 domain) 330456-25-2 98.83%
    Tau Peptide (275-305) (Repeat 2 domain) is the Alzheimer's Tau fragment R2, corresponding to the second repeat unit of the microtubule-binding domain, which is believed to be pivotal to the biochemical properties of full tau protein. Tau Peptide (275-305) specifically coordinates with group IIB metal ions (Zn²⁺, Cd²⁺, Hg²⁺), which can induce their conformational changes and significantly promote their pathological accumulation. Tau Peptide (275-305) can be used to study the role of heavy metals in neurodegenerative diseases.
    Tau Peptide (275-305) (Repeat 2 domain)
  • HY-P4943
    Tau Peptide (273-284) 1663490-91-2 98.81%
    Tau Peptide (273-284) is a Tau fragment. Tau Peptide (273-284) can be used in the research of tauopathies, especially Alzheimer's disease.
    Tau Peptide (273-284)
  • HY-P4933
    Tau Peptide (255-314) (Repeat 2 Domain) (human) 2022995-68-0
    Tau Peptide (255-314) (Repeat 2 Domain) (human) (Tau-F protein (255-314)) is a polypeptide. Tau Peptide (255-314) (human) is the 255-314 fragment of Tau-F (also known as Tau-4, the 2N4 isoform), a major isoform of the Tau protein. Tau Peptide (255-314) (human) contains two core driving sequences for Tau aggregation, namely PHF6* (275-280, VQIINK) and PHF6 (306-311, VQIVYK), and spans the C-terminal half of repeat domain R1, the entire repeat domain R2, and the N-terminal half of repeat domain R3 within the microtubule-binding region (MTBR).
    Tau Peptide (255-314) (Repeat 2 Domain) (human)
  • HY-P0181
    Microtubule-associated protein tau (26-44) 98.10%
    Microtubule-associated protein tau (26-44) is a synthetic peptide chain with an amine group attached to glutamine and an carboxyl group attached to lysine.
    Microtubule-associated protein tau (26-44)
  • HY-P4966
    Tau Peptide (306-336) (Repeat 3 Domain) 330456-26-3
    Tau Peptide (306-336) (Repeat 3 Domain) is aTau fragment.
    Tau Peptide (306-336) (Repeat 3 Domain)
  • HY-P4968
    Tau Peptide (337-368) (Repeat 4 Domain) 330456-27-4 98.90%
    Tau Peptide (337-368) (Repeat 4 Domain) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
    Tau Peptide (337-368) (Repeat 4 Domain)
  • HY-P4977
    Tau Peptide (74-102) (Exon 3/Insert 2 Domain) 1322695-34-0
    Tau Peptide (74-102) (Exon 3/Insert 2 Domain) is aTau fragment.
    Tau Peptide (74-102) (Exon 3/Insert 2 Domain)
  • HY-P4972
    Tau Peptide (45-73) (Exon 2/Insert 1 Domain) 2022956-54-1
    Tau Peptide (45-73) (Exon 2/Insert 1 Domain) is aTau fragment.
    Tau Peptide (45-73) (Exon 2/Insert 1 Domain)
  • HY-P4969
    Tau Peptide (379-408) 1246357-53-8
    Tau Peptide (379-408) is aTau fragment.
    Tau Peptide (379-408)
  • HY-P4960
    Tau Peptide (294-305) (human) 1428135-29-8
    Tau Peptide (294-305) (human) is aTau fragment.
    Tau Peptide (294-305) (human)
  • HY-P4927
    Tau Peptide (245-274) (Repeat 1 Domain) 1428134-39-7
    Tau Peptide (245-274) (Repeat 1 Domain) is aTau fragment.
    Tau Peptide (245-274) (Repeat 1 Domain)
  • HY-P4924
    Tau Peptide (244-274) (Repeat 1 Domain) 330456-24-1
    Tau Peptide (244-274) (Repeat 1 Domain) is aTau fragment.
    Tau Peptide (244-274) (Repeat 1 Domain)
  • HY-P4923
    Tau Peptide (1-16) (human) 2022956-53-0
    Tau Peptide (1-16) (human) is aTau fragment.
    Tau Peptide (1-16) (human)
  • HY-P4967
    Tau Peptide (307-321) 330456-50-3
    Tau Peptide (307-321) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
    Tau Peptide (307-321)
  • HY-P4965
    Tau Peptide (306-317) 1003007-59-7
    Tau Peptide (306-317) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
    Tau Peptide (306-317)
  • HY-P4964
    Tau Peptide (304-318) 330456-49-0
    Tau Peptide (304-318) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
    Tau Peptide (304-318)
  • HY-P4963
    Tau Peptide (301-315) 330456-48-9
    Tau Peptide (301-315) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development.
    Tau Peptide (301-315)